INVESTIGATION OF 1,5-ANHYDROGLUCITOL CONCENTRATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Lâm Vĩnh Niên1,, Nguyễn Nguyệt Quỳnh Mai1
1 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: 1,5-AG is a reflective of short-term blood glucose status that cannot be monitored with the HbA1c test. Objective: to investigate the change of 1,5-AG concentration in normal people and people with type 2 diabetes. Methods: Cross-sectional study design compared with the change of 1,5-Anhydroglucitol concentration between 2 groups of patients with diabetes (189) and without diabetes (150). Conducted at the Department of Biochemistry - Military Medical Hospital 175 - Ho Chi Minh City from February 2020 to July 2020. Results: 1.5-AG was significantly low in patients with type 2 diabetes, the average concentration was 9.7 ± 7.6 μg/ml, compared with the group of people without diabetes was 23.3 ± 8, 1 μg/ml, lower is statistically significant (p < 0.001). In the group of type 2 diabetes, there was no difference in the concentration of 1.5-AG by sex, the concentrations in men and women were: 9.1 ± 7.7 μg/ml, 10.4 ± 7.5, respectively. μg/ml (p = 0.184). The concentration of 1,5-AG in subjects without diabetes did not have a statistically significant difference when dividing by age group, at the age of < 40, 40 - 49, 50 - 59 years old, over 60 years old, respectively 17.9 ± 6.0 μg/ml, 22.7 ± 7.8 μg/ml, 23.3 ± 7.8μg/ml, 24.0±8.5μg/ml (p=0.111) ). Conclusion: Quantification of 1,5-AG has the ability to control blood sugar, especially in cases requiring short-term assessment.

Article Details

References

1. D. R. Whiting (2011), "IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030", Diabetes Res Clin Pract. 94(3), 311-21.
2. S. E. Siegelaar (2010), "Glucose variability; does it matter?", Endocr Rev. 31(2), 171-82.
3. D. E. Goldstein (2004), "Tests of glycemia in diabetes", Diabetes Care. 27(7), 1761-73.
4. B. I. Freedman (2010), "Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis", Perit Dial Int. 30(1), 72-9.
5. W. J. Kim C. Y. Park (2013), "1,5-Anhydroglucitol in diabetes mellitus", Endocrine. 43(1), 33-40.
6. Y. Wang (2012), "A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China", Diabetes Metab Res Rev. 28(4), 357-62.
7. Quỳnh Hoa Lương (2013), Đánh giá giá trị của fructosamine huyết thanh trong theo dõi hiệu quả điều trị ở bệnh nhân đái tháo đường týp 2, Luận văn Y học, Đại học Y Hà Nội.
8. Thị Kim Châu Đoàn, Thị Hồng Nhung Phạm Nguyễn Trọng Phú Trần (2016), "Nghiên cứu thực trạng kiểm soát đường huyết thông qua HbA1C và một số chỉ số khác trên bệnh nhân đái tháo đường típ 2 tại khoa khám bệnh, bệnh viện Đại học Y Dược Cần Thơ năm 2015 - 2016", Tạp chí Y Dược học Cần Thơ. 8, 144 - 151
9. Y. Wang (2017), "Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes", Acta Diabetol. 54(5), 425-431.
10. M. Dworacka H. Winiarska (2005), "The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients", Dis Markers. 21(3), 127-32.